Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WuXi AppTec H | Hong Kong | Salute | Ricerca medica e biotecnologica | 173,97 Mrd HKD | 19x | -1,32 | 56,85 HKD | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8,4% Rialzo | Fai l’upgrade a Pro+ | |
Beigene | Hong Kong | Salute | Ricerca medica e biotecnologica | 169,72 Mrd HKD | -41,2x | -0,6 | 123,20 HKD | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 39,7% Rialzo | Fai l’upgrade a Pro+ | |
WuXi Biologics | Hong Kong | Salute | Ricerca medica e biotecnologica | 70,26 Mrd HKD | 19,4x | -0,67 | 17,12 HKD | -2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,2% Rialzo | Fai l’upgrade a Pro+ | |
Akeso | Hong Kong | Salute | Ricerca medica e biotecnologica | 60,99 Mrd HKD | -77,1x | 0,56 | 67,95 HKD | 2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 2,7% Rialzo | Fai l’upgrade a Pro+ | |
Tigermed | Hong Kong | Salute | Ricerca medica e biotecnologica | 57,48 Mrd HKD | 59,5x | -0,96 | 37,85 HKD | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 12,8% Rialzo | Fai l’upgrade a Pro+ | |
Pharmaron Beijing Co Ltd | Hong Kong | Salute | Ricerca medica e biotecnologica | 53,67 Mrd HKD | 28,8x | 1,24 | 16,06 HKD | -3,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18% Rialzo | Fai l’upgrade a Pro+ | |
Sichuan Kelun Biotech | Hong Kong | Salute | Ricerca medica e biotecnologica | 39 Mrd HKD | -188x | -2,84 | 175 HKD | -4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 22,9% Rialzo | Fai l’upgrade a Pro+ | |
Genscript Biotech Corp | Hong Kong | Salute | Ricerca medica e biotecnologica | 23,16 Mrd HKD | -16,7x | -3,59 | 10,88 HKD | -6,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Remegen | Hong Kong | Salute | Ricerca medica e biotecnologica | 16,93 Mrd HKD | -6,1x | 0,59 | 18,62 HKD | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,9% Rialzo | Fai l’upgrade a Pro+ | |
Joinn Laboratories China Co | Hong Kong | Salute | Ricerca medica e biotecnologica | 14,38 Mrd HKD | -19.610x | 10,50 HKD | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -23,9% Ribasso | Fai l’upgrade a Pro+ | ||
Innocare | Hong Kong | Salute | Ricerca medica e biotecnologica | 14,35 Mrd HKD | -21x | -0,59 | 7,03 HKD | 3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 22,4% Rialzo | Fai l’upgrade a Pro+ | |
Ascentage Pharma | Hong Kong | Salute | Ricerca medica e biotecnologica | 13,67 Mrd HKD | -34,3x | -0,56 | 44,10 HKD | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8% Rialzo | Fai l’upgrade a Pro+ | |
Lepu Biopharma | Hong Kong | Salute | Ricerca medica e biotecnologica | 12,78 Mrd HKD | -49,2x | -0,83 | 3,25 HKD | 6,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lepu Biopharma | Hong Kong | Salute | Ricerca medica e biotecnologica | 12,78 Mrd HKD | -49,2x | -0,83 | 3,25 HKD | 6,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Keymed Biosciences | Hong Kong | Salute | Ricerca medica e biotecnologica | 12,32 Mrd HKD | -13,4x | 0,09 | 44,70 HKD | 3,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 28,1% Rialzo | Fai l’upgrade a Pro+ | |
CARsgen Therapeutics Holdings | Hong Kong | Salute | Ricerca medica e biotecnologica | 4,15 Mrd HKD | -3,5x | -0,22 | 7,56 HKD | 12,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -10,1% Ribasso | Fai l’upgrade a Pro+ | |
Alphamab | Hong Kong | Salute | Ricerca medica e biotecnologica | 3,98 Mrd HKD | -10,7x | -43,81 | 4,13 HKD | 6,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -18,9% Ribasso | Fai l’upgrade a Pro+ | |
Abbisko Cayman | Hong Kong | Salute | Ricerca medica e biotecnologica | 3,08 Mrd HKD | -121,8x | -1,81 | 4,92 HKD | 11,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Qyuns Therapeutics | Hong Kong | Salute | Ricerca medica e biotecnologica | 2,80 Mrd HKD | -11x | 12,60 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
ImmuneOnco Biopharmaceuticals | Hong Kong | Salute | Ricerca medica e biotecnologica | 2,79 Mrd HKD | -5,4x | -10,67 | 7,45 HKD | 2,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
CStone | Hong Kong | Salute | Ricerca medica e biotecnologica | 2,50 Mrd HKD | -15,8x | -0,2 | 1,96 HKD | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,7% Rialzo | Fai l’upgrade a Pro+ | |
Biocytogen Pharmaceuticals Beijing | Hong Kong | Salute | Ricerca medica e biotecnologica | 2,40 Mrd HKD | -11,1x | -0,17 | 6,01 HKD | -2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Frontage Holdings | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,96 Mrd HKD | 40,4x | -0,64 | 0,97 HKD | 5,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hua Medicine | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,77 Mrd HKD | -6x | 0,16 | 1,80 HKD | 5,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Mabpharm | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,44 Mrd HKD | -5,9x | 0,97 | 0,35 HKD | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Jacobio Pharmaceuticals Group | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,40 Mrd HKD | -3,7x | -0,26 | 1,77 HKD | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Tot Biopharm Intl | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,31 Mrd HKD | 140,9x | 1,14 | 1,69 HKD | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 40,9% Rialzo | Fai l’upgrade a Pro+ | |
Wuhan YZY Biopharma | Hong Kong | Salute | Ricerca medica e biotecnologica | 1,06 Mrd HKD | -5,8x | -0,72 | 5,48 HKD | -5,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Genor Biopharma Holdings | Hong Kong | Salute | Ricerca medica e biotecnologica | 939,47 Mln HKD | -1,6x | -0,14 | 1,82 HKD | -1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Immunotech | Hong Kong | Salute | Ricerca medica e biotecnologica | 926,25 Mln HKD | -3,8x | 0,77 | 1,80 HKD | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |